PALSONIFY

PALTUSOTINE · Crinetics Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PALSONIFY, covering 2025-09-25 to 2026-08-03. Get the full timeline:

Most recent: EMA Authorised: Palsonify (paltusotine hydrochloride) — Crinetics Pharmaceuticals Europe GmbH